E-cigarette vapor contains more carcinogenic formaldehyde than regular cigarettes
the ONA take:
E-cigarette vapor may contain cancer-causing formaldehyde at a level 15 times higher than normal cigarettes, according to a new study published in the New England Journal of Medicine.
“We’ve found that there is a hidden form of formaldehyde in e-cigarette vapor that has not typically been measured,” said James Pankow, PhD, co-author of the study along with fellow researchers at Portland State University in Oregon. “People shouldn’t assume these e-cigarettes are completely safe.”
While once believed to be a less harmful alternative to the formaldehyde and toxic chemicals found in the smoke of normal cigarettes, newer e-cigarettes operate at high temperatures that dramatically boost the creation of formaldehyde-containing compounds.
The researchers found that, at high voltage, formaldehyde-releasing agents in e-cigarettes increased a person’s lifetime risk of cancer by five-to-15 times greater than the risk of long-term smoking with regular cigarettes. However, the compounds were not found when they were operated at a lower voltage.
The American Vaping Association, an advocacy group for e-cigarette makers, criticized the study, stating that users wouldn’t normally operate devices at such a high voltage.
E-cigarettes remain unregulated, and representatives from the American Cancer Society stated that the findings from the study stress the importance of FDA oversight.
E-cigarette vapor may contain cancer-causing formaldehyde at a level 15 times higher than normal cigarettes.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|